Investigational New Drug Application (IND)

BACK TO GLOSSARY

An Investigational New Drug Application (IND) is a request for authorization from the Food and Drug Administration (FDA) to administer an investigational drug or biological product to humans. Once an application is submitted, the FDA has 30 calendar days to review. The FDA will not approve or clear the IND application. If no clinical hold is put placed within that time, then the Investigator may proceed.

About the Author
Proxima CRO Team
Bufo Areh
Clinical Research Associate

Nwabufo obtained his B.Sc. in Biotechnology with a minor in Business Administration from the Richard Stockton University, New Jersey. Nwabufo has over four years of global experience in a variety of therapeutic areas, including cardiovascular, oncology, ophthalmology, infectious diseases, CNS, and metabolic diseases as a clinical research associate.

Related FAQs:
More Questions? We're here to help!
SPEAK WITH A SPECIALIST